Literature DB >> 47262

Carcinoembryonic antigen and alpha fetoprotein in malignant tumors of the female genital tract.

M Seppälä, H Pihko, E Ruoslahti.   

Abstract

Circulating carcinoembryonic antigen (CEA) and alpha fetoprotein (AFP) levels were measured by radioimmunoassay in 53 patients with carcinoma of the ovary, 16 patients with other malignant genital tumors, and 31 women with nonmalignant diseases of the genital tract. The serum CEA concentration was elevated (greater than 5 ng/ml) in 11 patients with ovarian cancer, 2 patients with endometrial cancer, 1 patient with carcinoma of the cervix, and 1 patient with a benign embryonal cystic teratoma. Elevated CEA levels were found only in patients with advanced malignant disease, while early stages were associated with normal CEA concentrations. AFP levels were normal in all but 1 patient. Both CEA and AFP levels were markedly raised in a case of advanced genital carcinoma arising probably from the ovary. Ascitic fluid of another patient with ovarian cancer contained a high concentration of CEA, giving an identical reaction in immunodiffusion with CEA from colon cancer. The present results indicate that while the increased expression of carcinofetal components takes place in some malignant tumors of the female genital tract, it is usually a late phenomenon.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47262     DOI: 10.1002/1097-0142(197505)35:5<1377::aid-cncr2820350521>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Phase I/II Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma.

Authors:  Benjamin Cahan; Lucille Leong; Lawrence Wagman; David Yamauchi; Stephen Shibata; Sharon Wilzcynski; Lawrence E Williams; Paul Yazaki; David Colcher; Paul Frankel; Anna Wu; Andrew Raubitschek; John Shively; Jeffrey Y C Wong
Journal:  Cancer Biother Radiopharm       Date:  2017-09       Impact factor: 3.099

2.  Development of a multimarker assay for early detection of ovarian cancer.

Authors:  Zoya Yurkovetsky; Steven Skates; Aleksey Lomakin; Brian Nolen; Trenton Pulsipher; Francesmary Modugno; Jeffrey Marks; Andrew Godwin; Elieser Gorelik; Ian Jacobs; Usha Menon; Karen Lu; Donna Badgwell; Robert C Bast; Anna E Lokshin
Journal:  J Clin Oncol       Date:  2010-04-05       Impact factor: 44.544

3.  The detection and measurement of oncodevelopmental proteins in gynecological malignant disease.

Authors:  C Cerni; G Tatra
Journal:  Arch Gynecol       Date:  1982

4.  Clinical significance of measurements of carcinoembryonic antigen in serum of patients with carcinoma of the uterine cervix.

Authors:  P Braun; G Hildenbrand; J Izbicki; G Leyendecker
Journal:  Arch Gynecol       Date:  1981

5.  Morphology of the spleen in women who died of metastatic genital tract cancer.

Authors:  K J Syrjänen
Journal:  Arch Gynecol       Date:  1980

6.  Products of gynaecological neoplasms: clinical and pathological applications.

Authors:  A M Neville
Journal:  Arch Gynecol       Date:  1980

7.  Tumour-associated immune responses and isolated carcinoembryonic antigen and alpha feto-protein levels related to survival in ovarian cancer patients.

Authors:  L Levin; J E McHardy; T A Poulton; O M Curling; M J Kitau; A M Neville; C N Hudson
Journal:  Br J Cancer       Date:  1976-04       Impact factor: 7.640

8.  Oncofoetal antigens in cancer of the cervix and ovary.

Authors:  M N Cauchi; S H Koh; D Lim; D L Hay
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.